Prof Jarad Martin

1.1K posts

Prof Jarad Martin banner
Prof Jarad Martin

Prof Jarad Martin

@DocJarad

Radiation Oncologist who treats and researches #prostatecancer, gastrointestinal cancers & benign diseases. Dabbles in #mathematics. Views my own.

Newcastle, Australia Katılım Mayıs 2012
258 Takip Edilen1.6K Takipçiler
Prof Jarad Martin retweetledi
ASTRO
ASTRO@ASTRO_org·
TODAY! ASTRO’s first ever Functional Radiation Medicine Grand Rounds Join us on today, Thursday, Feb. 26 at 4:00 p.m. ET Jarad Martin, PhD, ChB, MB, and Peter Gorayski, BMBS, present emerging evidence on the application of low-dose radiation therapy for nonmalignant conditions such as Osteoarthritis, Plantar Fasciitis, and Ledderhose Disease. @DocJarad @PeterGorayski Organized by ASTRO's new Functional Radiation Medicine Task Force. Register here for this FREE event: ow.ly/9FlM50Y3S9U
ASTRO tweet media
English
2
3
6
438
Prof Jarad Martin retweetledi
ASTRO
ASTRO@ASTRO_org·
Register FREE for ASTRO’s first Functional Radiation Medicine Grand Rounds New Date - Join us on Thursday, February 26 at 4:00 p.m. ET! Jarad Martin, PhD, ChB, MB, and Peter Gorayski, BMBS, present emerging evidence on the application of low-dose radiation therapy for nonmalignant conditions such as Osteoarthritis, Plantar Fasciitis, and Ledderhose Disease. @DocJarad @PeterGorayski Organized by ASTRO's new Functional Radiation Medicine Task Force. Register FREE for this inaugural event: ow.ly/9FlM50Y3S9U
ASTRO tweet media
English
1
4
6
486
Prof Jarad Martin retweetledi
ASTRO
ASTRO@ASTRO_org·
Register FREE for ASTRO’s first Functional Radiation Medicine Grand Rounds Join us on Wednesday, February 25 at 4:00 p.m. ET as Jarad Martin, PhD, ChB, MB, and Peter Gorayski, BMBS, present emerging evidence on the application of low-dose radiation therapy for nonmalignant conditions such as Osteoarthritis, Plantar Fasciitis, and Ledderhose Disease. @DocJarad @PeterGorayski Organized by ASTRO's new Functional Radiation Medicine Task Force. Register FREE for this inaugural event: ow.ly/9FlM50Y3S9U
ASTRO tweet media
English
0
8
10
916
Prof Jarad Martin retweetledi
Sameer Keole
Sameer Keole@SameerKeoleMD·
Thanks for sharing! The @ASTRO_org 2025 AM in San Francisco (Sep 27-Oct 1) will have a 3 hr symposium on Sun featuring RT for non-malignant disease, including cardiac. Your fellow Aussie, @DocJarad, is helping put it together. See you this Fall, if not sooner!
Shankar Siva@_ShankarSiva

Our little Oz 🦘🇦🇺experience of cardiac ablation for 💔ventricular arrhythmia. 50-day author link here; authors.elsevier.com/c/1kiIB5VtUyaE…. Pictures say a thousand words! Or in this case, re-wiring a few cardiac circuits 😀 @PeterMacRadOnc #radonc

English
2
3
17
1.9K
Prof Jarad Martin
Prof Jarad Martin@DocJarad·
ProPSMA - the gift that keeps on giving! Great to be part of such an impactful collaboration.
Michael Hofman@DrMHofman

Longer follow-up from our landmark ProPSMA study just out @EurUrolOncol: PSMA nodal status is prognostic! At 3 years 70% of patients without nodal involvement (N0) disease free, vs. only 46% if N1 CT-defined nodal status is not prognostic. Read the details here: authors.elsevier.com/sd/article/S25… Super team: @declangmurphy @veerukasi @ButeauJames @lawrentschuk @mj_robbo @DocJarad @mfrydenberg @DrAIravani ProPSMA sponsored by @PeterMacCC Funded by @PCFA @MovemberAUS @pros_tic supported by @PCF_Science

English
1
2
17
990
Prof Jarad Martin
Prof Jarad Martin@DocJarad·
Brachytherapy doses of radiotherapy delivered non-invasively for prostate cancer with 94.1% 5-year control and low rates of significant toxicity. Now being investigated in randomised trials such as @TROGfightcancer NINJA and @GETUG_Unicancer PEACE 7.
European Urology Oncology@EurUrolOncol

Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial by @drericwegener et al buff.ly/3Nc1hC5 #UroSoMe #MedTwitter #EUO

English
0
8
16
2.5K
Prof Jarad Martin retweetledi
Alison Tree 💙
Alison Tree 💙@alison_tree·
Tell me again why we can’t use renal SBRT in the UK?!? 100% local control is hard to beat. Masterclass by @_ShankarSiva #ASTRO24
Alison Tree 💙 tweet media
English
10
62
255
20.3K
Prof Jarad Martin
Prof Jarad Martin@DocJarad·
I struggle with when to consider testosterone replacement for symptomatic men with controlled disease after ADT. After either six or 18 months of ADT, spontaneous recovery is rare after the two year mark, so some great data to inform shared decision making.
Prof Jarad Martin tweet media
Amar Kishan@AmarUKishan

Pleased to share the newest MARCAP publication, out in @EUplatinum -- the TRANSPORT analysis of T recovery after ADT for localized PCa, led by @weeloonong and Tahmineh Romero Free share link: authors.elsevier.com/a/1joOX14kplyz…

English
2
19
41
7.4K
Prof Jarad Martin retweetledi
Pierre Blanchard, MD
Pierre Blanchard, MD@PBlanchardMD·
Transdermal estradiol as a new option for testosterone lowering vs LHRHa : similar MFS & OS but different toxicity than LHRHa (less hot flashes, higher bone mineral density...) Open Qs: 1. efficacy vs antagonists 2. combination with other drugs (ARPI, PARPi) or RT #ESMO2024
Pierre Blanchard, MD tweet mediaPierre Blanchard, MD tweet mediaPierre Blanchard, MD tweet mediaPierre Blanchard, MD tweet media
English
5
28
39
4.5K
Prof Jarad Martin retweetledi
Quite Interesting
Quite Interesting@qikipedia·
Word of the Day: PSEUDOGLOT (neologism) - one who knows a few basic words in many languages and pretends to be a polyglot.
English
19
63
594
80.5K
Keith Siau
Keith Siau@drkeithsiau·
Little stars seen on colonoscopy in a patient with lower GI bleeding. What’s the diagnosis?
Keith Siau tweet media
English
52
45
494
133.6K
Dr. Nina Niu Sanford
Dr. Nina Niu Sanford@NiuSanford·
What imaging do you use to follow anal cancer patients s/p chemoRT? We do: PET at 10-12 weeks & if still uptake, another ~3 mo later. Once normalized, CT CAP q6-12 mo. But this isn't consistent w NCCN guidelines – which recommends no f/u PET, no short-term imaging at all.
Dr. Nina Niu Sanford tweet media
English
11
8
33
4.1K
Prof Jarad Martin
Prof Jarad Martin@DocJarad·
@gnioannou @stevenbollipo Great start. We might now consider some local therapy like SBRT as an attempt to consolidate disease control before it becomes refractive to systemic therapy. 🤔
English
1
0
2
76
George Ioannou
George Ioannou@gnioannou·
Large, infiltrative hepatocellular carcinomas with vascular invasion CAN melt away with immunotherapy (atezolizumab + bevacizumab).🙂🙂 ➡️Reduction in AFP from >20,000 down to 5 after six cycles of atezo/bev❗️ + No more vascular invasion on MRI. Amazing!
George Ioannou tweet media
English
2
2
29
2.3K
Prof Jarad Martin retweetledi
Dr. Andrew Loblaw
Dr. Andrew Loblaw@DrAndrewLoblaw·
100% agree @DrSpratticus Here's a popular #HIFU company's web posting... Vs data they reference vs other published data... (note their ref has no RP nor RT data). Yes failure def'n different for RP vs RT but drives salvage = more toxicity Maybe they need to hire new webmaster?
Dr. Andrew Loblaw tweet mediaDr. Andrew Loblaw tweet media
Daniel E Spratt@DrSpratticus

Can’t emphasize the importance of this being done on trial as patients can’t have informed consent without good data. All treatments have side effects and they need to understand their choices based on quality data and not misguided advertising that is rampant (including medonc and radonc for those thinking this is only urology groups).

English
2
7
32
25.5K

Keşfet

@PeterGorayski @ANZUPtrials @PCFA @CancerAustralia @Prof_IanD @ASTRO_org @NEJM @alison_tree